These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12672327)

  • 21. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
    Watson TJ; Peters JH
    Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastro-oesophageal reflux disease--current concepts in management.
    Piterman L; Nelson M; Dent J
    Aust Fam Physician; 2004 Dec; 33(12):987-91. PubMed ID: 15630919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimizing symptom relief and preventing complications in adults with gastro-oesophageal reflux disease.
    Savarino V; Dulbecco P
    Digestion; 2004; 69 Suppl 1():9-16. PubMed ID: 15001830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroesophageal reflux disease: new treatments.
    Katz PO
    Rev Gastroenterol Disord; 2002; 2(2):66-74. PubMed ID: 12122962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the diagnosis and management of GORD in adults.
    Hopper AD
    Practitioner; 2015 Apr; 259(1781):27-32, 3. PubMed ID: 26529827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocinch therapy for gastro-oesophageal reflux disease: a one year prospective follow up.
    Mahmood Z; McMahon BP; Arfin Q; Byrne PJ; Reynolds JV; Murphy EM; Weir DG
    Gut; 2003 Jan; 52(1):34-9. PubMed ID: 12477756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A current assessment of endoluminal approaches to the treatment of gastroesophageal reflux disease.
    Portale G; Filipi CJ; Peters JH
    Surg Innov; 2004 Dec; 11(4):225-34. PubMed ID: 15756391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD)--a reappraisal 10 years on.
    Pace F; Bollani S; Molteni P; Bianchi Porro G
    Dig Liver Dis; 2004 Feb; 36(2):111-5. PubMed ID: 15002817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of proton pump inhibitors in gastro-oesophageal reflux disease.
    Dekel R; Morse C; Fass R
    Drugs; 2004; 64(3):277-95. PubMed ID: 14871170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK.
    Remák E; Brown RE; Yuen C; Robinson A
    Curr Med Res Opin; 2005 Oct; 21(10):1505-17. PubMed ID: 16238890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical and economic impact of competing management strategies for gastro-oesophageal reflux disease.
    Ofman JJ; Dorn GH; Fennerty MB; Fass R
    Aliment Pharmacol Ther; 2002 Feb; 16(2):261-73. PubMed ID: 11860409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis.
    Molina-Infante J; van Rhijn BD
    Best Pract Res Clin Gastroenterol; 2015 Oct; 29(5):749-758. PubMed ID: 26552774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.
    Chang AB; Lasserson TJ; Gaffney J; Connor FL; Garske LA
    Cochrane Database Syst Rev; 2005 Apr; (2):CD004823. PubMed ID: 15846735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised clinical trial: oesophageal radiofrequency energy delivery versus sham for PPI-refractory heartburn.
    Zerbib F; Sacher-Huvelin S; Coron E; Coffin B; Melchior C; Ponchon T; Cholet F; Chabrun E; Vavasseur F; Gorbatchef C; Zalar A; Mion F; Robaszkiewicz M; Le Rhun M; Leroy M; Paul Galmiche J; Bruley des Varannes S
    Aliment Pharmacol Ther; 2020 Aug; 52(4):637-645. PubMed ID: 32656869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
    Kahrilas PJ; Hughes N; Howden CW
    Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.
    Ekesbo R; Sjöstedt S; Sörngård H
    Clin Drug Investig; 2011; 31(3):181-9. PubMed ID: 21288053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trial.
    Kappelle WF; Bredenoord AJ; Conchillo JM; Ruurda JP; Bouvy ND; van Berge Henegouwen MI; Chiu PW; Booth M; Hani A; Reddy DN; Bogte A; Smout AJ; Wu JC; Escalona A; Valdovinos MA; Torres-Villalobos G; Siersema PD
    Aliment Pharmacol Ther; 2015 Sep; 42(5):614-25. PubMed ID: 26153531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: long-term use of proton pump inhibitors in GORD--help or hindrance?
    Tytgat GN
    Aliment Pharmacol Ther; 2001 Sep; 15 Suppl 2():6-9. PubMed ID: 11556874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical treatment of gastro-oesophageal reflux disease.
    De Giorgi F; Savarese MF; Atteo E; Leone CA; Cuomo R
    Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):276-80. PubMed ID: 17345932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.